These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1427651)

  • 1. Hepatitis C virus infection in medical personnel after needlestick accident.
    Mitsui T; Iwano K; Masuko K; Yamazaki C; Okamoto H; Tsuda F; Tanaka T; Mishiro S
    Hepatology; 1992 Nov; 16(5):1109-14. PubMed ID: 1427651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents.
    Sodeyama T; Kiyosawa K; Urushihara A; Matsumoto A; Tanaka E; Furuta S; Akahane Y
    Arch Intern Med; 1993 Jul; 153(13):1565-72. PubMed ID: 7686741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of polymerase chain reaction for early detection and management of hepatitis C virus infection after needlestick injury.
    Wang TY; Kuo HT; Chen LC; Chen YT; Lin CN; Lee MM
    Ann Clin Lab Sci; 2002; 32(2):137-41. PubMed ID: 12017194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The management of acute hepatitis C and needlestick accidents with hepatitis-C virus positive blood].
    Cooreman MP; Weegink C; Reesink HW
    Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2298-300. PubMed ID: 9864524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
    Sugiyasu T
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection: other biological fluids than blood may be responsible for intrafamilial spread.
    Mastromatteo AM; Rapaccini GL; Pompili M; Ursino S; Romano-Spica V; Gasbarrini G; Vanini G
    Hepatogastroenterology; 2001; 48(37):193-6. PubMed ID: 11268963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.
    Chemello L; Cavalletto D; Pontisso P; Bortolotti F; Donada C; Donadon V; Frezza M; Casarin P; Alberti A
    Hepatology; 1993 Feb; 17(2):179-82. PubMed ID: 8381380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel.
    Chung H; Kudo M; Kumada T; Katsushima S; Okano A; Nakamura T; Osaki Y; Kohigashi K; Yamashita Y; Komori H; Nishiuma S
    J Gastroenterol; 2003; 38(9):877-9. PubMed ID: 14569445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
    Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
    Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.
    Roudot-Thoraval F; Pawlotsky JM; Thiers V; Deforges L; Girollet PP; Guillot F; Huraux C; Aumont P; Brechot C; Dhumeaux D
    Hepatology; 1993 May; 17(5):772-7. PubMed ID: 7684017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.